Munafa Stock Market Course + Intraday & FNO calls 
Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)
Technical Analysis Report for USA stock AKTX Akari Therapeutics. Dated: 05 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics
Akari Therapeutics Opened at 0.32 and Closed at: 0.29, which is 0% of previous session's close. It moved within a range of 0.29 and 0.32
The session was a Bearish session with an average volume of 408400, which is -5.07% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 0.28 and resistance for tomorrow is 0.31
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.28, 0.27 resistance for tomorrow's hourly charts is 0.31, 0.33
10 Day SMA for Akari Therapeutics (AKTX) is 0.27 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Akari Therapeutics (AKTX) is 0.3 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Akari Therapeutics (AKTX) is 0.47 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.67 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Akari Therapeutics is 0.94 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Akari Therapeutics is at 0.3 and 200 DMA is at 0.94, while 50 DMA and 100 DMA are at 0.47 and 0.67 respectively
Akari Therapeutics (AKTX) moving average of 20 SMA is at 0.3 and 20 EMA is at 0.32
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Jan | 0.29 | 0.3 | 0.32 |
| 02 Fri Jan | 0.29 | 0.31 | 0.32 |
| 31 Wed Dec | 0.29 | 0.31 | 0.32 |
| 30 Tue Dec | 0.27 | 0.31 | 0.32 |
| 29 Mon Dec | 0.26 | 0.32 | 0.33 |
| 26 Fri Dec | 0.27 | 0.33 | 0.34 |
Akari Therapeutics (AKTX) moving average of 50 SMA is at 0.47 and 50 EMA is at 0.45
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Jan | 0.29 | 0.47 | 0.45 |
| 02 Fri Jan | 0.29 | 0.48 | 0.46 |
| 31 Wed Dec | 0.29 | 0.49 | 0.47 |
| 30 Tue Dec | 0.27 | 0.5 | 0.48 |
| 29 Mon Dec | 0.26 | 0.51 | 0.49 |
| 26 Fri Dec | 0.27 | 0.52 | 0.5 |
Akari Therapeutics (AKTX) moving average of 100 SMA is at 0.67 and 100 EMA is at 0.57
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Jan | 0.29 | 0.67 | 0.57 |
| 02 Fri Jan | 0.29 | 0.68 | 0.58 |
| 31 Wed Dec | 0.29 | 0.69 | 0.59 |
| 30 Tue Dec | 0.27 | 0.69 | 0.6 |
| 29 Mon Dec | 0.26 | 0.7 | 0.61 |
| 26 Fri Dec | 0.27 | 0.71 | 0.62 |
Akari Therapeutics (AKTX) moving average of 200 SMA is at 0.94 and 200 EMA is at 0.82
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Jan | 0.29 | 0.94 | 0.82 |
| 02 Fri Jan | 0.29 | 0.95 | 0.83 |
| 31 Wed Dec | 0.29 | 0.95 | 0.84 |
| 30 Tue Dec | 0.27 | 0.95 | 0.85 |
| 29 Mon Dec | 0.26 | 0.96 | 0.86 |
| 26 Fri Dec | 0.27 | 0.96 | 0.87 |
Novo Nordisk has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Novo Nordisk, about 29.88% more returns!
Encompass Health has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Encompass Health, about 10.46% more returns!
Chemed Corp has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Chemed Corp, about 18.5% more returns!
Sutro Biopharma has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Sutro Biopharma, about 40.23% more returns!
Rockwell Medical has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Rockwell Medical, about 14.71% more returns!
Pavmed Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Pavmed Inc, about 2141.98% more returns!
Omeros Corporation has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Omeros Corporation, about 56.51% more returns!
Marker Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Marker Therapeutics, about 50.32% more returns!
Icon Plc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Icon Plc, about 21.01% more returns!
Akari Therapeutics has performed better than Genprex Inc in short term. Holding Akari Therapeutics could be a better choice for now!
Guardant Health has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Guardant Health, about 14.56% more returns!
Enanta Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 9.98% more returns!
Ensign Group has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Ensign Group, about 13.9% more returns!
Cytokinetics Incorporated has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 7.99% more returns!
Celcuity Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Celcuity Inc, about 12.98% more returns!
Biotelemetry Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Biotelemetry Inc, about 290.05% more returns!
Argenx Se has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Argenx Se, about 3.58% more returns!
Amgen Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 11.93% more returns!
Align Technology has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Align Technology, about 16.57% more returns!
Akari Therapeutics Technical analysis of indicators
Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Akari Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Akari Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.27 and Akari Therapeutics AKTX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.
Akari Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AKTX Experts View which covers a lot of information including buying and selling signals
AKTX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
